Loading...
Symbols:
Loading...
Symbols:
Vertex Pharmaceuticals Inc. (VRTX)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Vertex Pharmaceuticals Inc. (VRTX)
55 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on VRTX
- SA Editors(10)
- A. Reza Saadat(6)
- Travis Johnson(6)
- Bespoke Investment Group(6)
- Robert Zenilman(5)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(572)
- SA Editor Eli Hoffmann(386)
- Andrew Wilkinson(333)
- SA Editor Rachael Granby(176)
- SA Editor Joan Wickham(145)
Most commented on authors
- SA Editor Joan Wickham(16)
- SA Editor Rachael Granby(9)
- A. Reza Saadat(6)
- Chad Brand(5)
- BioBlogger (5)
- Nasdaq 100 Struggles
- 5 Potential Buyout Targets in Biotech - Barron's
- Earnings Preview: Vertex Pharmaceuticals
- Big Biotech Booms But IBB Falls Flat
- Biotech Fundamentals Still Look Strong
- Russell 1,000 Stocks Up and Down the Most Since the 3/10 Bottom
- FDA's "Risky Business" for Pharma & Biotech
- Schering Beat the Street and Plows Through Vytorin Firestorm
- Stocks with Biggest Gains Last Week; Furthest Above 50-DMAs
- Best and Worst Performers Since the 3/10 Bottom
- Vertex's Telaprevir May Become a Multi-Billion Dollar Drug
- Vytorin Battle Pits Merck and SGP against Pfizer
- Insider Buying in Biotech Land
- Healthcare Stocks Have Been Anything but Defensive
- Earnings Preview: Vertex Pharmaceuticals
- Hepatitis C Developments Drag Biotechs Down
- 2007 Biotech Performance Review
- Pharma, Biotech Present Great Investment Opportunities in 2008
- Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile
- Retail Investors Should Grasp Opportunity In Vertex Pharmaceuticals
- Thursday's Options Report: Citigroup, Bank of America, Google, SunTrust, Vertex Pharma
- PBE: Large Biotech Meets Small Biotech
- Russell 1,000 Stocks Furthest From Their 50-Day Moving Averages
- Vertex Pharmaceutical's Hepatitis Drug Proves Effective, But Path To Market Unclear
- Organic Growth Stocks That Should Lead the Pack
- Vertex Optimistic on Hepatitis C Drug
- Biotech Indices Mixed as AMEX Gains, Nasdaq Slips
- Vertex Hepititis C Drug: A Potential Blockbuster
- Investors Infected With Vertex Fever Should Seek Healthier Stocks -- Barron's
- Vertex May Win Race for Hepatitis C Drug
- Searching for Shorts
- Earnings Season Thoughts on Google, MEMC, Akamai, Intuitive Surgical and Vertex
- Chart: Biotech Stocks - Annual Earnings Growth
- Chart: Biotech Stocks - Quarterly Earnings Growth
- Chart: Biotech Stocks - Annual Revenue Growth (Last 12 Months Reported)
- Chart: Biotech Stocks - Quarterly Revenue Growth
- Vertex Pharaceuticals' Deal with J&J Makes Good Sense (VRTX)
- Chart: Biotech Stocks - Change in Cash-On-Hand
-
Chart: Biotech Stocks - Normalized Net Income Per Employee
on Jun 09, 2006
- Chart: Biotech Stocks - Revenue Per Employee
- Chart: Biotech Stocks - Normalized Net Profit Margins
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »